Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    17706495 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Withdrawn Prenatal Steroids for Treatment of Congenital Cystic Adenomatoid Malformations (CCAM)
Condition: Congenital Cystic Adenomatoid Malformation
Interventions: Drug: Betamethasone;   Drug: Placebo

Indicates status has not been verified in more than two years